Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thoracic Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT02595450
What this trial is testing

A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 299
Large-scale testing (Phase 3)Active Not RecruitingNCT06569420
What this trial is testing

Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung CancerALK-positiveSAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 275
Testing effectiveness (Phase 2)UnknownNCT03983759
What this trial is testing

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive DiseaseAdoptive Cellular Immunotherapy+2 more
Henan Cancer Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Testing effectiveness (Phase 2)Ended earlyNCT00359450
What this trial is testing

Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)

Who this might be right for
Non-small Cell Lung Cancer
Bristol-Myers Squibb 186
Large-scale testing (Phase 3)Study completedNCT00132613
What this trial is testing

Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion

Who this might be right for
Malignant Pericardial Effusion
Japan Clinical Oncology Group 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT03838159
What this trial is testing

NADIM II: Neo-Adjuvant Immunotherapy

Who this might be right for
Non Small Cell Lung Cancer
Fundación GECP 90
Large-scale testing (Phase 3)UnknownNCT01405079
What this trial is testing

Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 222
Not applicableStudy completedNCT02663817
What this trial is testing

DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy

Who this might be right for
Head and Neck CancerLung CancerProstate Cancer
University of Miami 52
Not applicableUnknownNCT02904850
What this trial is testing

Validation of a Kinetic Model of Erlotinib

Who this might be right for
Lung Cancer
University Hospital, Strasbourg, France 50
Not applicableStudy completedNCT02080650
What this trial is testing

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Who this might be right for
Prostate CancerRenal Cell CarcinomaBladder Cancer+5 more
Duke University 62
Large-scale testing (Phase 3)Study completedNCT04028050
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 155
Testing effectiveness (Phase 2)Ended earlyNCT00544674
What this trial is testing

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Proacta, Incorporated 5
Testing effectiveness (Phase 2)Ended earlyNCT00299390
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 10
Testing effectiveness (Phase 2)Ended earlyNCT04352413
What this trial is testing

PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Not applicableLooking for participantsNCT07241182
What this trial is testing

Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy

Who this might be right for
Lung Cancer (Diagnosis)
Tri-Service General Hospital (TSGH) 40
Testing effectiveness (Phase 2)Looking for participantsNCT06790082
What this trial is testing

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

Who this might be right for
Pleural MesotheliomaPleural DiseasesCancer+2 more
Aalborg University Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01636934
What this trial is testing

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 51
Next Page